Tracking COVID–19 Variants Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 4, 2021)
Tracking COVID-19 Variants Act
This bill expands viral genomic sequencing, disease surveillance, and other public health research activities.
Specifically, the Centers for Disease Control and Prevention (CDC) must issue guidance on the sequencing of the virus that causes COVID-19 (i.e., coronavirus disease 2019). Additionally, the CDC must establish a program to strengthen genomic sequencing, analytics, and disease surveillance activities. As part of this program, the CDC must provide grants and technical assistance to health departments to build their capacity to carry out such activities.
Furthermore, the National Center for Health Statistics (NCHS) must carry out a demonstration program to expand an existing program that links different federal data sets for statistical public health research, including research on food insecurity, housing instability, and other social determinants of health. In particular, the program must support linkages with the National Death Index, a database of death records maintained by the NCHS.
What just happenedFeb 5, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseFeb 4, 2021
- Feb 5, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 4, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 4, 2021IntroReferralIntro-H
Introduced in House
- Feb 4, 2021IntroReferral1000
Introduced in House